Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses

Vaccine

Volumn 29, Issue 28, 2011, Pages 4584-4592

  Hunter, Zoe ^a   Tumban, Ebenezer ^a   Dziduszko, Agnieszka ^a   Chackerian, Bryce ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Aerosol; HPV; Mucosal immunity; VLP

Indexed keywords

ANTIBODY; BACTERIOPHAGE Q BETA VACCINE; CAPSID PROTEIN; CAPSID PROTEIN L2; HPV16 L1 L2 VIRUS LIKE PARTICLE VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MEDROXYPROGESTERONE ACETATE; PEPTIDE; RECOMBINANT 16L2 PP7 VIRUS LIKE PARTICLE VACCINE; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIOPHAGE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL SYSTEM; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; SERUM; VIRUS PARTICLE; VIRUS STRAIN;

ADMINISTRATION, INTRAVAGINAL; AEROSOLS; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CAPSID PROTEINS; FEMALE; GENITAL DISEASES, FEMALE; HUMAN PAPILLOMAVIRUS 16; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; VACCINES, VIRUS-LIKE PARTICLE; VIRION;

EID: 79958137861     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.051     Document Type: Article

References (32)

1. Belyakov I.M., Ahlers J.D. What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?. J Immunol 2009, 183(December (11)):6883-6892.
2. Lowy D.R., Schiller J.T. Prophylactic human papillomavirus vaccines. J Clin Invest 2006, 116(May (5)):1167-1173.
3. Plummer E.M., Manchester M. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010, September.
4. Chackerian B., Durfee M.R., Schiller J.T. Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model. J Immunol 2008, 180(May (9)):5816-5825.
5. Storni T., Ruedl C., Schwarz K., Schwendener R.A., Renner W.A., Bachmann M.F. Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. J Immunol 2004, 172(February (3)):1777-1785.
6. Hunter Z., Smyth H.D., Durfee P., Chackerian B. Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine. Vaccine 2009, 28(December (2)):403-414.
7. Alphs H.H., Gambhira R., Karanam B., Roberts J.N., Jagu S., Schiller J.T., et al. Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2. Proc Natl Acad Sci USA 2008, 105(April (15)):5850-5855.
8. Chackerian B., Rangel M., Hunter Z., Peabody D.S. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses. Vaccine 2006, 24(September (37-39)):6321-6331.
9. Buck C.B., Pastrana D.V., Lowy D.R., Schiller J.T. Efficient intracellular assembly of papillomaviral vectors. J Virol 2004, 78(January (2)):751-757.
10. Buck C.B., Thompson C.D., Pang Y.Y., Lowy D.R., Schiller J.T. Maturation of papillomavirus capsids. J Virol 2005, 79(March (5)):2839-2846.
11. Caldeira Jdo C., Medford A., Kines R.C., Lino C.A., Schiller J.T., Chackerian B., et al. Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7. Vaccine 2010, 28(June (27)):4384-4393.
12. Roberts J.N., Buck C.B., Thompson C.D., Kines R., Bernardo M., Choyke P.L., et al. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 2007, 13(July (7)):857-861.
13. Johnson K.M., Kines R.C., Roberts J.N., Lowy D.R., Schiller J.T., Day P.M. Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol 2009, 83(March (5)):2067-2074.
14. Wira C.R., Sullivan D.A. Estradiol and progesterone regulation of immunoglobulin A and G and secretory component in cervicovaginal secretions of the rat. Biol Reprod 1985, 32(February (1)):90-95.
15. Cuburu N., Kweon M.N., Hervouet C., Cha H.R., Pang Y.Y., Holmgren J., et al. Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection. J Immunol 2009, 183(December (12)):7851-7859.
16. Fraillery D., Zosso N., Nardelli-Haefliger D. Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles. Vaccine 2009, 27(April (17)):2326-2334.
17. Mesquita P.M., Cheshenko N., Wilson S.S., Mhatre M., Guzman E., Fakioglu E., et al. Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety. J Infect Dis 2009, 200(August (4)):599-608.
18. Di Tommaso A., Saletti G., Pizza M., Rappuoli R., Dougan G., Abrignani S., et al. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect Immun 1996, 64(March (3)):974-979.
19. Gallichan W.S., Woolstencroft R.N., Guarasci T., McCluskie M.J., Davis H.L., Rosenthal K.L. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract. J Immunol 2001, 166(March (5)):3451-3457.
20. Klavinskis L.S., Barnfield C., Gao L., Parker S. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. J Immunol 1999, 162(January (1)):254-262.
21. Morrison L.A., Da Costa X.J., Knipe D.M. Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge. Virology 1998, 243(March (1)):178-187.
22. VanCott T.C., Kaminski R.W., Mascola J.R., Kalyanaraman V.S., Wassef N.M., Alving C.R., et al. HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160. J Immunol 1998, 160(February (4)):2000-2012.
23. Hervouet C., Luci C., Cuburu N., Cremel M., Bekri S., Vimeux L., et al. Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract. Vaccine 2010, 28(August (34)):5582-5590.
24. Echchannaoui H., Bianchi M., Baud D., Bobst M., Stehle J.C., Nardelli-Haefliger D. Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer. Infect Immun 2008, 76(May (5)):1940-1951.
25. Wegmann F., Krashias G., Luhn K., Laamanen K., Vieira S., Jeffs S.A., et al. A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment. PLoS ONE 2011, 6(1):e15861.
26. Graham B.S., Kines R.C., Corbett K.S., Nicewonger J., Johnson T.R., Chen M., et al. Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination. Mucosal Immunol 2010 Sep, 3(5):475-486.
27. Kozlowski P.A., Williams S.B., Lynch R.M., Flanigan T.P., Patterson R.R., Cu-Uvin S., et al. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J Immunol 2002, 169(July (1)):566-574.
28. Lenz P., Day P.M., Pang Y.Y., Frye S.A., Jensen P.N., Lowy D.R., et al. Papillomavirus-like particles induce acute activation of dendritic cells. J Immunol 2001, 166(May (9)):5346-5355.
29. Rudolf M.P., Fausch S.C., Da Silva D.M., Kast W.M. Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro. J Immunol 2001, 166(10):5917-5924.
30. Bachmann M.F., Schwarz K., Wolint P., Meijerink E., Martin S., Manolova V., et al. Cutting edge: distinct roles for T help and CD40/CD40 ligand in regulating differentiation of proliferation-competent memory CD8+ T cells. J Immunol 2004, 173(August (4)):2217-2221.
31. Iwasaki A. Antiviral immune responses in the genital tract: clues for vaccines. Nat Rev Immunol 2010, 10(October (10)):699-711.
32. Wira C.R., Fahey J.V., Sentman C.L., Pioli P.A., Shen L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 2005, August (206):306-335.